🇺🇸 FDA
Patent

US 12084515

Compositions and methods for treatment of diabetic macular edema

granted A61KA61K2039/505A61K2039/54

Quick answer

US patent 12084515 (Compositions and methods for treatment of diabetic macular edema) held by Takeda Pharmaceutical Company Limited expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Sep 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K2039/505, A61K2039/54, A61K9/0051, A61P